Literature DB >> 18418489

Vibrio vulnificus Septicemia After Handling Tilapia Species Fish: A Canadian Case Report and Review.

Donald C Vinh1, Samira Mubareka, Bunmi Fatoye, Pierre Plourde, Pamela Orr.   

Abstract

BACKGROUND: Vibrio vulnificus can cause a necrotizing soft tissue infection or primary septicemia; these infections are collectively known as vibriosis. This bacterium is commonly found within molluscan shellfish. Primary septicemia is often fatal, principally affecting persons with chronic liver disease. CASE
PRESENTATION: A fatal case of V vulnificus sepsis that developed in a patient with chronic hepatitis B and chronic renal failure is reported. Diagnosis was made by isolation of the pathogen by blood culture. Upon further questioning, the patient's family recounted that the patient had handled and ingested Tilapia species fish in the hours preceding the patient's presentation. Despite treatment with doxycycline and cefotaxime, in conjunction with supportive care in the intensive care unit, the patient died on day 7 from multiple organ dysfunction.
CONCLUSION: The present case highlights the need to consider V vulnificus in the microbiological differential diagnosis when a person presents with sepsis and bullous cutaneous lesions. The importance of educating patients with liver disease (and certain other chronic diseases) about the need to be cautious when handling or consuming seafood is underscored.

Entities:  

Keywords:  Bullae; Canada; Fish; Liver; Sepsis; Vibrio vulnificus

Year:  2006        PMID: 18418489      PMCID: PMC2095056          DOI: 10.1155/2006/164681

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  37 in total

1.  Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group.

Authors:  N Bisharat; V Agmon; R Finkelstein; R Raz; G Ben-Dror; L Lerner; S Soboh; R Colodner; D N Cameron; D L Wykstra; D L Swerdlow; J J Farmer
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

2.  A case of Plesiomonas shigelloides cellulitis and bacteraemia from northern Europe.

Authors:  I Jönsson; T Monsen; J Wiström
Journal:  Scand J Infect Dis       Date:  1997

3.  In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.

Authors:  Hung-Jen Tang; Ming-Chung Chang; Wen-Chien Ko; Kun-Yen Huang; Chih-Lung Lee; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 4.  Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature.

Authors:  J A Jernigan; B M Farr
Journal:  Clin Infect Dis       Date:  2000-08-30       Impact factor: 9.079

5.  Cellulitis and compartment syndrome due to Plesiomonas shigelloides: a case report.

Authors:  V Gopal; F E Burns
Journal:  Mil Med       Date:  1991-01       Impact factor: 1.437

6.  Distribution and ecology of Vibrio vulnificus and other lactose-fermenting marine vibrios in coastal waters of the southeastern United States.

Authors:  J D Oliver; R A Warner; D R Cleland
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

7.  Aeromonas hydrophila myonecrosis and gas gangrene in a nonimmunocompromised host.

Authors:  P S Heckerling; T M Stine; J C Pottage; S Levin; A A Harris
Journal:  Arch Intern Med       Date:  1983-10

Review 8.  Infections with Vibrio vulnificus.

Authors:  Michael Borenstein; Francisco Kerdel
Journal:  Dermatol Clin       Date:  2003-04       Impact factor: 3.478

9.  Aeromonas hydrophila bacteremia in ambulatory immunocompromised hosts.

Authors:  R L Wolff; S L Wiseman; C S Kitchens
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965

Review 10.  Vibrio vulnificus in Taiwan.

Authors:  Po-Ren Hsueh; Ching-Yih Lin; Hung-Jen Tang; Hsin-Chun Lee; Jien-Wei Liu; Yung-Ching Liu; Yin-Ching Chuang
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  7 in total

1.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

2.  Necrotizing wound infection from a tilapia fish injury.

Authors:  Raistlin Alexander Majere; Sandra Cortina
Journal:  CMAJ       Date:  2017-04-10       Impact factor: 8.262

3.  Genetic characterization of Vibrio vulnificus strains from tilapia aquaculture in Bangladesh.

Authors:  Zahid H Mahmud; Anita C Wright; Shankar C Mandal; Jianli Dai; Melissa K Jones; Mahmud Hasan; Mohammad H Rashid; Mohammad S Islam; Judith A Johnson; Paul A Gulig; J Glenn Morris; Afsar Ali
Journal:  Appl Environ Microbiol       Date:  2010-05-21       Impact factor: 4.792

Review 4.  The regulator HlyU, the repeat-in-toxin gene rtxA1, and their roles in the pathogenesis of Vibrio vulnificus infections.

Authors:  Moqing Liu; Jorge H Crosa
Journal:  Microbiologyopen       Date:  2012-11-28       Impact factor: 3.139

5.  Comparative transcriptome analysis reveals ectopic delta-5 and delta-6 desaturases enhance protective gene expression upon Vibrio vulnificus challenge in Tilapia (Oreochromis niloticus).

Authors:  Pin-Yang Tu; Shin-Jie Huang; Venugopal Rajanbabu; Jen-Leih Wu; Jyh-Yih Chen
Journal:  BMC Genomics       Date:  2021-03-22       Impact factor: 3.969

6.  Identification and whole-genome sequencing analysis of Vibrio vulnificus strains causing pearl gentian grouper disease in China.

Authors:  Zun Wu; Yating Wu; Haofeng Gao; Xuexin He; Qiang Yao; Zhanglei Yang; Jinyi Zhou; Linting Ji; Jinwei Gao; Xuying Jia; Yong Dou; Xiaoyu Wang; Peng Shao
Journal:  BMC Microbiol       Date:  2022-08-16       Impact factor: 4.465

Review 7.  Vibriosis Outbreaks in Aquaculture: Addressing Environmental and Public Health Concerns and Preventive Therapies Using Gilthead Seabream Farming as a Model System.

Authors:  Gracinda M M Sanches-Fernandes; Isabel Sá-Correia; Rodrigo Costa
Journal:  Front Microbiol       Date:  2022-07-11       Impact factor: 6.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.